PubMed

Progress in basic and clinical research on HIV resistance: report on the XVIII International HIV Drug Resistance Workshop.

Mascolini M, Boucher CA, Mellors JW, Larder BA, Richman DD.

Antivir Ther. 2009;14(7):1015-37.PMID: 19918107 [PubMed - in process]Related articles

Evaluation of a rapid molecular algorithm for detection of pandemic influenza A (H1N1) 2009 virus and screening for a key oseltamivir resistance (H275Y) substitution in neuraminidase.

van der Vries E, Jonges M, Herfst S, Maaskant J, Van der Linden A, Guldemeester J, Aron GI, Bestebroer TM, Koopmans M, Meijer A, Fouchier RA, Osterhaus AD, Boucher CA, Schutten M.

J Clin Virol. 2009 Oct 24. [Epub ahead of print]PMID: 19857993 [PubMed - as supplied by publisher]Related articles

Transmission of drug-resistant HIV-1 is stabilizing in Europe.

Vercauteren J, Wensing AM, van de Vijver DA, Albert J, Balotta C, Hamouda O, Kücherer C, Struck D, Schmit JC, Asjö B, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Horban A, Korn K, Kostrikis L, Nielsen C, Paraskevis D, Poljak M, Puchhammer-Stöckl E, Riva C, Ruiz L, Salminen M, Schuurman R, Sonnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher CA.

J Infect Dis. 2009 Nov 15;200(10):1503-8.PMID: 19835478 [PubMed - indexed for MEDLINE]Related articles

Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V.

Nijhuis M, Wensing AM, Bierman WF, de Jong D, Kagan R, Fun A, Jaspers CA, Schurink KA, van Agtmael MA, Boucher CA.

J Infect Dis. 2009 Sep 1;200(5):698-709.PMID: 19627247 [PubMed - indexed for MEDLINE]Related articles

Pathogenesis and transmission of swine-origin 2009 A(H1N1) influenza virus in ferrets.

Munster VJ, de Wit E, van den Brand JM, Herfst S, Schrauwen EJ, Bestebroer TM, van de Vijver D, Boucher CA, Koopmans M, Rimmelzwaan GF, Kuiken T, Osterhaus AD, Fouchier RA.

Science. 2009 Jul 24;325(5939):481-3. Epub 2009 Jul 2.PMID: 19574348 [PubMed - indexed for MEDLINE]Related articles

HIV decision support: from molecule to man.

Sloot PM, Coveney PV, Ertaylan G, Müller V, Boucher CA, Bubak M.

Philos Transact A Math Phys Eng Sci. 2009 Jul 13;367(1898):2691-703.PMID: 19487205 [PubMed - in process]Related articlesFree article

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach.

Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman I, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, Macrae E, Maljkovic-Berry I, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen MO, Schmit JC, Schuurman R, Soriano V, Stanczak J, Stanojevic M, Struck D, Van Laethem K, Violin M, Yerly S, Zazzi M, Boucher CA, Vandamme AM; SPREAD Programme.

Retrovirology. 2009 May 20;6:49.PMID: 19457244 [PubMed - indexed for MEDLINE]Related articlesFree article

Novel mechanisms of HIV protease inhibitor resistance.

Nijhuis M, van Maarseveen NM, Verheyen J, Boucher CA.

Curr Opin HIV AIDS. 2008 Nov;3(6):627-32.PMID: 19373034 [PubMed - in process]Related articles

Circulating HIV type 1 drug resistance will have limited impact on the effectiveness of preexposure prophylaxis among young women in Zimbabwe.

van de Vijver DA, Derdelinckx I, Boucher CA.

J Infect Dis. 2009 May 1;199(9):1310-7.PMID: 19301982 [PubMed - indexed for MEDLINE]Related articles

Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update.

Bennett DE, Camacho RJ, Otelea D, Kuritzkes DR, Fleury H, Kiuchi M, Heneine W, Kantor R, Jordan MR, Schapiro JM, Vandamme AM, Sandstrom P, Boucher CA, van de Vijver D, Rhee SY, Liu TF, Pillay D, Shafer RW.

PLoS One. 2009;4(3):e4724. Epub 2009 Mar 6.PMID: 19266092 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV-1 can persist in aged memory CD4+ T lymphocytes with minimal signs of evolution after 8.3 years of effective highly active antiretroviral therapy.

Nottet HS, van Dijk SJ, Fanoy EB, Goedegebuure IW, de Jong D, Vrisekoop N, van Baarle D, Boltz V, Palmer S, Borleffs JC, Boucher CA.

J Acquir Immune Defic Syndr. 2009 Apr 1;50(4):345-53.PMID: 19214126 [PubMed - indexed for MEDLINE]Related articles

Broad advances in understanding HIV resistance to antiretrovirals: report on the XVII International HIV Drug Resistance Workshop.

Mascolini M, Larder BA, Boucher CA, Richman DD, Mellors JW.

Antivir Ther. 2008;13(8):1097-113.PMID: 19195337 [PubMed - indexed for MEDLINE]Related articles

Occult hepatitis B in persons infected with HIV is associated with low CD4 counts and resolves during antiretroviral therapy.

Cohen Stuart JW, Velema M, Schuurman R, Boucher CA, Hoepelman AI.

J Med Virol. 2009 Mar;81(3):441-5.PMID: 19152397 [PubMed - indexed for MEDLINE]Related articles

HIV monotherapy with ritonavir-boosted protease inhibitors: a systematic review.

Bierman WF, van Agtmael MA, Nijhuis M, Danner SA, Boucher CA.

AIDS. 2009 Jan 28;23(3):279-91. Review.PMID: 19114854 [PubMed - indexed for MEDLINE]Related articles

Antiviral resistance and impact on viral replication capacity: evolution of viruses under antiviral pressure occurs in three phases.

Nijhuis M, van Maarseveen NM, Boucher CA.

Handb Exp Pharmacol. 2009;(189):299-320. Review.PMID: 19048205 [PubMed - indexed for MEDLINE]Related articles

Radiopharmaceutical agents for myocardial perfusion imaging.

Baggish AL, Boucher CA.

Circulation. 2008 Oct 14;118(16):1668-74. Review. No abstract available. PMID: 18852377 [PubMed - indexed for MEDLINE]Related articlesFree article

Rational use of antiretroviral therapy in low-income and middle-income countries: optimizing regimen sequencing and switching.

Elliott JH, Lynen L, Calmy A, De Luca A, Shafer RW, Zolfo M, Clotet B, Huffam S, Boucher CA, Cooper DA, Schapiro JM.

AIDS. 2008 Oct 18;22(16):2053-67. Review. No abstract available. PMID: 18753937 [PubMed - indexed for MEDLINE]Related articles

Clinical implications of resistance to antiretrovirals: new resistance technologies and interpretations.

Mascolini M, Richman D, Larder B, Mellors J, Boucher CA.

Antivir Ther. 2008;13(2):319-34.PMID: 18505183 [PubMed - indexed for MEDLINE]Related articles

Ninety-nine is not enough: molecular characterization of inhibitor-resistant human immunodeficiency virus type 1 protease mutants with insertions in the flap region.

Kozísek M, Sasková KG, Rezácová P, Brynda J, van Maarseveen NM, De Jong D, Boucher CA, Kagan RM, Nijhuis M, Konvalinka J.

J Virol. 2008 Jun;82(12):5869-78. Epub 2008 Apr 9.PMID: 18400858 [PubMed - indexed for MEDLINE]Related articlesFree article

Identification of a novel resistance (E40F) and compensatory (K43E) substitution in HIV-1 reverse transcriptase.

Huigen MC, van Ham PM, de Graaf L, Kagan RM, Boucher CA, Nijhuis M.

Retrovirology. 2008 Feb 13;5:20.PMID: 18271957 [PubMed - indexed for MEDLINE]Related articlesFree article

[HIV should become a notifiable disease]

Vlaminckx BJ, Boucher CA.

Ned Tijdschr Geneeskd. 2007 Dec 1;151(48):2672. Dutch. PMID: 18179084 [PubMed - indexed for MEDLINE]Related articles

Treatment response to ritonavir-boosted tipranavir versus ritonavir-boosted lopinavir in HIV-1 patients with higher lopinavir mutation scores.

Walmsley SL, Cotte L, Rusconi S, Ward DJ, Hicks CB, Meier U, Valdez H, Boucher CA.

AIDS. 2007 Oct 18;21(16):2245-8.PMID: 18090054 [PubMed - indexed for MEDLINE]Related articles

Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein.

Bosch BJ, Rossen JW, Bartelink W, Zuurveen SJ, de Haan CA, Duquerroy S, Boucher CA, Rottier PJ.

J Virol. 2008 Mar;82(5):2580-5. Epub 2007 Dec 12.PMID: 18077706 [PubMed - indexed for MEDLINE]Related articlesFree article

Evolution of a novel 5-amino-acid insertion in the beta3-beta4 loop of HIV-1 reverse transcriptase.

Huigen MC, de Graaf L, Eggink D, Schuurman R, Müller V, Stamp A, Stammers DK, Boucher CA, Nijhuis M.

Virology. 2007 Aug 1;364(2):395-406. Epub 2007 Apr 23.PMID: 17451772 [PubMed - indexed for MEDLINE]Related articles

Insertions in the beta3-beta4 loop of reverse transcriptase of human immunodeficiency virus type 1 and their mechanism of action, influence on drug susceptibility and viral replication capacity.

Eggink D, Huigen MC, Boucher CA, Götte M, Nijhuis M.

Antiviral Res. 2007 Aug;75(2):93-103. Epub 2007 Mar 26. Review.PMID: 17416429 [PubMed - indexed for MEDLINE]Related articles

HIV protease resistance and viral fitness.

Nijhuis M, van Maarseveen NM, Boucher CA.

Curr Opin HIV AIDS. 2007 Mar;2(2):108-15.PMID: 19372875 [PubMed - in process]Related articles

A novel substrate-based HIV-1 protease inhibitor drug resistance mechanism.

Nijhuis M, van Maarseveen NM, Lastere S, Schipper P, Coakley E, Glass B, Rovenska M, de Jong D, Chappey C, Goedegebuure IW, Heilek-Snyder G, Dulude D, Cammack N, Brakier-Gingras L, Konvalinka J, Parkin N, Kräusslich HG, Brun-Vezinet F, Boucher CA.

PLoS Med. 2007 Jan;4(1):e36.PMID: 17227139 [PubMed - indexed for MEDLINE]Related articlesFree article

Persistence of HIV-1 variants with multiple protease inhibitor (PI)-resistance mutations in the absence of PI therapy can be explained by compensatory fixation.

van Maarseveen NM, Wensing AM, de Jong D, Taconis M, Borleffs JC, Boucher CA, Nijhuis M.

J Infect Dis. 2007 Feb 1;195(3):399-409. Epub 2006 Dec 29.PMID: 17205479 [PubMed - indexed for MEDLINE]Related articles

Criteria for drugs used in pre-exposure prophylaxis trials against HIV infection.

Derdelinckx I, Wainberg MA, Lange JM, Hill A, Halima Y, Boucher CA.

PLoS Med. 2006 Nov;3(11):e454. Review. No abstract available. PMID: 17090213 [PubMed - indexed for MEDLINE]Related articlesFree article

HIV drug resistance tests are here to stay.

Boucher CA.

Curr Opin Infect Dis. 1999 Feb;12(1):27-32.PMID: 17035756 [PubMed]Related articles

Genotypic changes in human immunodeficiency virus type 1 protease associated with reduced susceptibility and virologic response to the protease inhibitor tipranavir.

Baxter JD, Schapiro JM, Boucher CA, Kohlbrenner VM, Hall DB, Scherer JR, Mayers DL.

J Virol. 2006 Nov;80(21):10794-801. Epub 2006 Aug 23.PMID: 16928764 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of mother-to-child transmission of multi-drug resistant HIV-1 using maternal therapy with both enfuvirtide and tipranavir.

Wensing AM, Boucher CA, van Kasteren M, van Dijken PJ, Geelen SP, Juttmann JR.

AIDS. 2006 Jun 26;20(10):1465-7. No abstract available. PMID: 16791028 [PubMed - indexed for MEDLINE]Related articles

An increase in viral replicative capacity drives the evolution of protease inhibitor-resistant human immunodeficiency virus type 1 in the absence of drugs.

van Maarseveen NM, de Jong D, Boucher CA, Nijhuis M.

J Acquir Immune Defic Syndr. 2006 Jun;42(2):162-8.PMID: 16645546 [PubMed - indexed for MEDLINE]Related articles

More than colocalizing with polycystin-1, polycystin-L is in the centrosome.

Bui-Xuan EF, Li Q, Chen XZ, Boucher CA, Sandford R, Zhou J, Basora N.

Am J Physiol Renal Physiol. 2006 Aug;291(2):F395-406. Epub 2006 Apr 11.PMID: 16609150 [PubMed - indexed for MEDLINE]Related articlesFree article

The calculated genetic barrier for antiretroviral drug resistance substitutions is largely similar for different HIV-1 subtypes.

van de Vijver DA, Wensing AM, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA.

J Acquir Immune Defic Syndr. 2006 Mar;41(3):352-60.PMID: 16540937 [PubMed - indexed for MEDLINE]Related articles

A novel real-time PCR assay to determine relative replication capacity for HIV-1 protease variants and/or reverse transcriptase variants.

van Maarseveen NM, Huigen MC, de Jong D, Smits AM, Boucher CA, Nijhuis M.

J Virol Methods. 2006 May;133(2):185-94. Epub 2005 Dec 20.PMID: 16368153 [PubMed - indexed for MEDLINE]Related articles

A Grid-based HIV expert system.

Sloot PM, Boukhanovsky AV, Keulen W, Tirado-Ramos A, Boucher CA.

J Clin Monit Comput. 2005 Oct;19(4-5):263-78.PMID: 16328942 [PubMed - indexed for MEDLINE]Related articles

Increased risk of early virological failure in non-European HIV-1-infected patients in a Dutch cohort on highly active antiretroviral therapy.

van den Berg JB, Hak E, Vervoort SC, Hoepelman IM, Boucher CA, Schuurman R, Schneider MM.

HIV Med. 2005 Sep;6(5):299-306.PMID: 16156876 [PubMed - indexed for MEDLINE]Related articles

Prevalence of drug-resistant HIV-1 variants in untreated individuals in Europe: implications for clinical management.

Wensing AM, van de Vijver DA, Angarano G, Asjö B, Balotta C, Boeri E, Camacho R, Chaix ML, Costagliola D, De Luca A, Derdelinckx I, Grossman Z, Hamouda O, Hatzakis A, Hemmer R, Hoepelman A, Horban A, Korn K, Kücherer C, Leitner T, Loveday C, MacRae E, Maljkovic I, de Mendoza C, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Paraskevis D, Perrin L, Puchhammer-Stöckl E, Ruiz L, Salminen M, Schmit JC, Schneider F, Schuurman R, Soriano V, Stanczak G, Stanojevic M, Vandamme AM, Van Laethem K, Violin M, Wilbe K, Yerly S, Zazzi M, Boucher CA; SPREAD Programme.

J Infect Dis. 2005 Sep 15;192(6):958-66. Epub 2005 Aug 15. Erratum in: J Infect Dis. 2005 Oct 15;192(8):1501. PMID: 16107947 [PubMed - indexed for MEDLINE]Related articles

An automated genotyping system for analysis of HIV-1 and other microbial sequences.

de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, Seebregts C, Snoeck J, van Rensburg EJ, Wensing AM, van de Vijver DA, Boucher CA, Camacho R, Vandamme AM.

Bioinformatics. 2005 Oct 1;21(19):3797-800. Epub 2005 Aug 2.PMID: 16076886 [PubMed - indexed for MEDLINE]Related articlesFree article

[Post-exposure prophylaxis following exposure to HIV: adaptation to the situation may be indicated]

Wensing AM, Schneider MM, Schurink CA, Geerlings SE, Boucher CA.

Ned Tijdschr Geneeskd. 2005 Jul 2;149(27):1485-9. Dutch. PMID: 16032990 [PubMed - indexed for MEDLINE]Related articles

Hepatitis C virus and human immunodeficiency virus coinfection: where do we stand?

Arends JE, Boucher CA, Hoepelman AI.

Neth J Med. 2005 May;63(5):156-63. Review.PMID: 15952483 [PubMed - indexed for MEDLINE]Related articlesFree article

[Patients co-infected with HIV and hepatitis-B virus (HBV): the favourable effect of lamivudine, as part of combined antiretroviral therapy, on HBV may be dependent upon the number of CD4-cells]

Smit MC, Haverkamp MH, Weersink AJ, Boucher CA, Hoepelman IM.

Ned Tijdschr Geneeskd. 2004 Nov 20;148(47):2330-4. Dutch. PMID: 15587052 [PubMed - indexed for MEDLINE]Related articles

Worldwide transmission of drug-resistant HIV.

Wensing AM, Boucher CA.

AIDS Rev. 2003 Jul-Sep;5(3):140-55. Review.PMID: 14598563 [PubMed - indexed for MEDLINE]Related articles

The effect of lamivudine on the replication of hepatitis B virus in HIV-infected patients depends on the host immune status (CD4 cell count).

Haverkamp M, Smit M, Weersink A, Boucher CA, Hoepelman AI.

AIDS. 2003 Jul 4;17(10):1572-4.PMID: 12824802 [PubMed - indexed for MEDLINE]Related articles

Therapeutic drug monitoring: an aid to optimising response to antiretroviral drugs?

Aarnoutse RE, Schapiro JM, Boucher CA, Hekster YA, Burger DM.

Drugs. 2003;63(8):741-53. Review.PMID: 12662123 [PubMed - indexed for MEDLINE]Related articles

Selection of zidovudine resistance mutations and escape of human immunodeficiency virus type 1 from antiretroviral pressure in stavudine-treated pediatric patients.

Maxeiner HG, Keulen W, Schuurman R, Bijen M, de Graaf L, van Wijk A, Back N, Kline MW, Boucher CA, Nijhuis M.

J Infect Dis. 2002 Apr 15;185(8):1070-6. Epub 2002 Apr 1.PMID: 11930317 [PubMed - indexed for MEDLINE]Related articles

Underestimation of HIV type 1 drug resistance mutations: results from the ENVA-2 genotyping proficiency program.

Schuurman R, Brambilla D, de Groot T, Huang D, Land S, Bremer J, Benders I, Boucher CA; ENVA Working Group.

AIDS Res Hum Retroviruses. 2002 Mar 1;18(4):243-8.PMID: 11860670 [PubMed - indexed for MEDLINE]Related articles

Genome sequence of the plant pathogen Ralstonia solanacearum.

Salanoubat M, Genin S, Artiguenave F, Gouzy J, Mangenot S, Arlat M, Billault A, Brottier P, Camus JC, Cattolico L, Chandler M, Choisne N, Claudel-Renard C, Cunnac S, Demange N, Gaspin C, Lavie M, Moisan A, Robert C, Saurin W, Schiex T, Siguier P, Thébault P, Whalen M, Wincker P, Levy M, Weissenbach J, Boucher CA.

Nature. 2002 Jan 31;415(6871):497-502.PMID: 11823852 [PubMed - indexed for MEDLINE]Related articles

How testing for HIV resistance influences therapeutic decision making. Analysis of a sample of 600 clinicians.

Mascolini M, Wensing AM, Boucher CA.

IAPAC Mon. 2001 Mar;7(3):85-90. No abstract available. PMID: 11697306 [PubMed - indexed for MEDLINE]Related articles